TH and metabolic dysfunction-associated steatotic liver disease: TH therapy, TRβ1 analogs, and liver-specific synthetic analogs in preclinical models and preliminary studies in patients with MASLD have shown promise as safe and potentially useful strategies in the treatment of MASLD.